Publications by authors named "Daniel Selchen"

Claim this Profile
I
Inflammatory Bowel Disease therapies and Demyelinating Diseases: A Practical Guide to Therapeutic Benefit and Risk.
Sailish Honap, Marc Debouverie, Massimo Filippi, Daniel Selchen, Vipul Jairath

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations.
Mark S Freedman, Fraser Clift, Virginia Devonshire, François Émond, Catherine Larochelle, Daniel Selchen

Can J Neurol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
Jim Christenson, Michael D Hill, Richard H Swartz, Corey Adams, Oscar Benavente, Daniel Selchen

Lancet· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic Neuritis.
Timothy Reynold Lim, Suradech Suthiphosuwan, Jonathan Micieli, Reza Vosoughi, Raphael Schneider, Daniel Selchen

AJNR Am J Neuroradiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies.
Vipul Jairath, Waqqas Afif, Brian Bressler, Janet E Pope, Daniel Selchen

J Can Assoc Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.
Jiwon Oh, Virender Bhan, Anthony Traboulsee, Sarah A Morrow, Liesly Lee, Daniel Selchen

Can J Neurol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study.
Sydney Lee, Alexandra Muccilli, Raphael Schneider, Daniel Selchen, Kristen M Krysko

Mult Scler· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Inhibition in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder.
Dubravka Dodig, Angela Genge, Daniel Selchen, Mark S Freedman

Can J Neurol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary.
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H Hua, Celia Oreja-Guevara, Daniel Selchen

Neurodegener Dis Manag· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Language discordance as a marker of disparities in cerebrovascular risk and stroke outcomes: A multi-center Canadian study.
Ryan T Muir, Arunima Kapoor, Megan L Cayley, Michelle N Sicard, Karen Lien, Daniel Selchen

Cereb Circ Cogn Behav· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence.
Celia Oreja-Guevara, Wallace Brownlee, Elisabeth G Celius, Diego Centonze, Gavin Giovannoni, Daniel Selchen

Mult Scler Relat Disord· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying gaps in the management of atrial fibrillation with anticoagulation for stroke prevention (GIANTS): a quality improvement initiative.
Phavalan Rajendram, Krystal Fox, Brindan Sivanandan, Daniel Selchen, Charles D Kassardjian

J Neurol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada.
Jacqueline M Solomon, Ashley Jones, Marika Hohol, Kristen M Krysko, Alexandra Muccilli, Daniel Selchen

Mult Scler Relat Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS.
Jiwon Oh, Suradech Suthiphosuwan, Pascal Sati, Martina Absinta, Blake Dewey, Daniel Selchen

Mult Scler· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H Hua, Celia Oreja-Guevara, Daniel Selchen

Ther Adv Neurol Disord· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and MRI characteristics of multiple sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada.
Estelle Seyman, Ashley Jones, Melanie Guenette, Reza Vosoughi, Daniel Selchen

Mult Scler· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion on the use of cladribine tablets in clinical practice.
Per Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, Xavier Montalban, Daniel Selchen

Ther Adv Neurol Disord· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing.
Mark S Freedman, Daniel Selchen, Alexandre Prat, Paul S Giacomini

Can J Neurol Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists.
Gustavo Saposnik, Xavier Montalban, Daniel Selchen, Maria A Terzaghi, Fabien Bakdache

Front Neurol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe aseptic temporal lobe encephalitis on fingolimod.
Dalia L Rotstein, Aditya Bharatha, Daniel Selchen

Mult Scler Relat Disord· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative spinal cord MRI in radiologically isolated syndrome.
Paula Alcaide-Leon, Kateryna Cybulsky, Stephanie Sankar, Courtney Casserly, General Leung, Daniel Selchen

Neurol Neuroimmunol Neuroinflamm· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response Time.
Charles D Kassardjian, Jacqueline D Willems, Krystyna Skrabka, Rosane Nisenbaum, Judith Barnaby, Daniel Selchen

Stroke· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.
Sylvain Lanthier, Gustavo Saposnik, Gerald Lebovic, Karen Pope, Daniel Selchen

Stroke· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).
Gustavo Saposnik, Angel P Sempere, Daniel Prefasi, Daniel Selchen, Christian C Ruff

Front Neurol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Gustavo Saposnik, Angel Perez Sempere, Roula Raptis, Daniel Prefasi, Daniel Selchen

BMC Neurol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis